11300 Federal Register / Vol. 66, No. 37 / Friday, February 23, 2001 / Notices

Agenda: To review and evaluate grant

applications.

Place: 6707 Democracy Boulevard,

Building II, Room 106, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Lawrence R. Haller,

National Center for Complementary and

Alternative Medicine, National Institutes of

Health, 31 Center Drive, Room 5B50,

Bethesda, MD 20892–2182, (301) 402–9011,

lh194t@nih.gov.

Dated: February 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4442 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel.

ZHL1–PPG–O–M1/Inflamation, Airways

Reactivity and Asthma Applications.

Date: March 7, 2001.

Time: 8 a.m. to 1 p.m.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Ave., Chevy Chase, MD 20815.

Contact Person: David T. George, MD, PhD,

Scientific Review Administrator, NIH,

NHLBI, DEA, Review Branch, Rockledge

Building II, Room 7188, 6701 Rockledge

Drive, MD 20892–7924, 301/435–0288.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: February 14, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4440 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Hear, Lung,

and Blood Institute Special Emphasis Panel.

ZHL–1–CSR–J–M4, Reference Laboratory to

Evaluate therapies for SCD Applications.

Date: March 15, 2001.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge II, Bethesda, MD

20892; (Telephone Conference Call).

Contact Person: Robert B. Moore, PhD,

Scientific Review Administrator, Review

Branch, Room 7192, Division of Extramural

Affairs, National Heart, Lung, and Blood

Institute, National Institutes of Health,

Bethesda, MD 20892, 301/435–3541.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: February 14, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4452 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel.

ZHL1 CSR–J M2 R Sibling Donor Cord Blood

Banking And Transplantation Applications.

Date: March 13, 2001.

Time: 3 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6701 Rockledge Dr. II, NIH,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Robert B Moore, PhD,

Scientific Review Administrator, Review

Branch, Room 7192, Division of Extramural

Affairs, National Heart, Lung, and Blood

Institute, National Institutes of Health,

Bethesda, MD 20892, 301/435–3541.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: February 14, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4453 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.